COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Myeloma-Developing Regimens Using Genomics (MyDRUG) (MyDRUG)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03732703
Recruitment Status : Recruiting
First Posted : November 7, 2018
Last Update Posted : December 3, 2019
Celgene Corporation
Eli Lilly and Company
Genentech, Inc.
Janssen, LP
Information provided by (Responsible Party):
Multiple Myeloma Research Consortium